Document is current
Any future updates will be listed below
-
Authors
Brown, Sherry-Ann
Daly, Ryan P.
Duma, Narjust
Yang, Eric H.
Pemmaraju, Naveen
Parwani, Purvi
Choi, Andrew D.
Lopez-Mattei, Juan http://orcid.org/0000-0002-1177-8761
- License Information
-
More Information
Article History
First Online: 13 August 2020
Compliance with Ethical Standards
:
: Sherry-Ann Brown declares that she has no conflict of interest. Ryan P. Daly serves as a social media consultant for JACC: CardioOncology Narjust Duma has received compensation from Inivata for service as a consultant. Eric H. Yang declares that he has no conflict of interest. Naveen Pemmaraju has received research funding from AbbVie, Stemline Therapeutics, Novartis, Samus Therapeutics, Cellectis, Plexxikon, Daiichi Sankyo, Affymetrix; is supported by grants from the Sager Strong Foundation and Dan’s House of Hope; has received compensation from AbbVie, Celgene, Stemline Therapeutics, Incyte, Novartis, Mustang Bio, Roche Diagnostics, and LFB for service as a consultant; and has served as a board member/volunteer for Dan’s House of Hope and the HemOnc Times/Oncology Times. Purvi Parwani has received compensation for service as a consultant on the Journal of the American College of Cardiology. Andrew D. Choi declares that he has no conflict of interest. Juan Lopez-Mattei has received compensation from Arterys for service as a consultant.
